EcoDrugPlus

Melatonin Receptor 1b

Ensembl ID : ENSSVLG00005023956
Gene Symbol: MTNR1B
1 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSSVLG00005006865
Gene Symbol: MME
1 Cross references
236 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSSVLG00005004789
Gene Symbol: METAP2
1 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSSVLG00005007091
Gene Symbol: MAPK1
1 Cross references
213 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSSVLG00005018125
Gene Symbol: MAPK10
1 Cross references
147 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSSVLG00005009538
Gene Symbol: MAPK11
1 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSSVLG00005002686
Gene Symbol: MAPK8
1 Cross references
293 Possible Orthologues:

Mitogen-Activated Protein Kinase 9

Ensembl ID : ENSSVLG00005005069
Gene Symbol: MAPK9
1 Cross references
163 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase 1

Ensembl ID : ENSSVLG00005024707
Gene Symbol: MAP2K1
1 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 1

Ensembl ID : ENSSVLG00005006689
Gene Symbol: MAP3K1
1 Cross references
160 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 10

Ensembl ID : ENSSVLG00005025865
Gene Symbol: MAP3K10
1 Cross references
185 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 11

Ensembl ID : ENSSVLG00005009961
Gene Symbol: MAP3K11
1 Cross references
183 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).